Friday – Basic Science Track A

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2026.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
Genetic engineering of novel BoNTs using Spycatcher bonding
Bazbek Davletov, PhD (UK)
Development and Optimization of Genetic Manipulation Systems in Group I Clostridium botulinum
Sho Amatsu, PhD (USA)
Probing the properties of PTEN specific botulinum toxin type E mutants
Thomas Binz, PhD (Germany)
Utilizing a Novel Botulinum Toxin to Investigate Intracellular Trafficking
Amber Robinson, Mres (UK)
Botulinum Neurotoxin A Mutants with Enhanced Ganglioside Binding Show Improved Potency and Altered Ganglioside Selectivity
Geoffrey Masuyer, PhD (Sweden)
The Membrane Localization Domain (MLD) of Botulinum Neurotoxin A1 is Essential for Its Long Duration of Action
Miriam Guevara, MS (USA)
YesNo
Genetic engineering of novel BoNTs using Spycatcher bonding
Bazbek Davletov, PhD (UK)
Development and Optimization of Genetic Manipulation Systems in Group I Clostridium botulinum
Sho Amatsu, PhD (USA)
Probing the properties of PTEN specific botulinum toxin type E mutants
Thomas Binz, PhD (Germany)
Utilizing a Novel Botulinum Toxin to Investigate Intracellular Trafficking
Amber Robinson, Mres (UK)
Botulinum Neurotoxin A Mutants with Enhanced Ganglioside Binding Show Improved Potency and Altered Ganglioside Selectivity
Geoffrey Masuyer, PhD (Sweden)
The Membrane Localization Domain (MLD) of Botulinum Neurotoxin A1 is Essential for Its Long Duration of Action
Miriam Guevara, MS (USA)
YesNo
Genetic engineering of novel BoNTs using Spycatcher bonding
Bazbek Davletov, PhD (UK)
Development and Optimization of Genetic Manipulation Systems in Group I Clostridium botulinum
Sho Amatsu, PhD (USA)
Probing the properties of PTEN specific botulinum toxin type E mutants
Thomas Binz, PhD (Germany)
Utilizing a Novel Botulinum Toxin to Investigate Intracellular Trafficking
Amber Robinson, Mres (UK)
Botulinum Neurotoxin A Mutants with Enhanced Ganglioside Binding Show Improved Potency and Altered Ganglioside Selectivity
Geoffrey Masuyer, PhD (Sweden)
The Membrane Localization Domain (MLD) of Botulinum Neurotoxin A1 is Essential for Its Long Duration of Action
Miriam Guevara, MS (USA)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Scam Warning

Due to scam emails being sent, please note that INA will NOT email you to wire money to anyone on the Board of Directors or anyone else from the INA.

Join Our Mailing List

Click here to sign up, and then manage your subscription.